General
Australia to trial ‘backup’ COVID-19 vaccines that can be modified to fight virus mutations
Researchers behind a clinical trial of two COVID-19 vaccines in Australia say they will be able to modify the vaccinations if mutations of the virus occur.
Key points:
- Researchers say the mRNA-based vaccine and recombinant protein vaccine being trialled are more targeted
- The Doherty Institute’s Terry Nolan says it is vital Australia has its own vaccine to prevent supply chain issues
- The trials have been expedited to mid-2021 with Federal Government funding
Close to $1.6 million of Federal Government money has been awarded to the Melbourne-based trial, with hopes it will begin around the middle of this year.
Plans to roll out small amounts of the Pfizer/BioNTech vaccine in Australia in March are still in place, before domestic production of…
-
Noosa News20 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News23 hours agoFrom Dreamy Dining Rooms to Moody Basement Bars, Nearly 200 Venues Have Been Shortlisted for the 2025 Australian Interior Design Awards
-
Noosa News21 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
General19 hours agoTruck driver charged with causing death by dangerous driving after highway crash